Your browser doesn't support javascript.
loading
Vorasidenib (AG-881): A First-in-Class, Brain-Penetrant Dual Inhibitor of Mutant IDH1 and 2 for Treatment of Glioma.
Konteatis, Zenon; Artin, Erin; Nicolay, Brandon; Straley, Kimberly; Padyana, Anil K; Jin, Lei; Chen, Yue; Narayaraswamy, Rohini; Tong, Shuilong; Wang, Feng; Zhou, Ding; Cui, Dawei; Cai, Zhenwei; Luo, Zhiyong; Fang, Cheng; Tang, Huachun; Lv, Xiaobing; Nagaraja, Raj; Yang, Hua; Su, Shin-San M; Sui, Zhihua; Dang, Lenny; Yen, Katharine; Popovici-Muller, Janeta; Codega, Paolo; Campos, Carl; Mellinghoff, Ingo K; Biller, Scott A.
Afiliación
  • Konteatis Z; Agios Pharmaceuticals, Inc., Cambridge, Massachusetts 02139, United States.
  • Artin E; Agios Pharmaceuticals, Inc., Cambridge, Massachusetts 02139, United States.
  • Nicolay B; Agios Pharmaceuticals, Inc., Cambridge, Massachusetts 02139, United States.
  • Straley K; Agios Pharmaceuticals, Inc., Cambridge, Massachusetts 02139, United States.
  • Padyana AK; Agios Pharmaceuticals, Inc., Cambridge, Massachusetts 02139, United States.
  • Jin L; Agios Pharmaceuticals, Inc., Cambridge, Massachusetts 02139, United States.
  • Chen Y; Agios Pharmaceuticals, Inc., Cambridge, Massachusetts 02139, United States.
  • Narayaraswamy R; Agios Pharmaceuticals, Inc., Cambridge, Massachusetts 02139, United States.
  • Tong S; Viva Biotech, Shanghai 201203, China.
  • Wang F; Wuxi Biortus Biosciences Co. Ltd, Jiangyin 214437, China.
  • Zhou D; PharmaResources, Shanghai 201201, China.
  • Cui D; PharmaResources, Shanghai 201201, China.
  • Cai Z; PharmaResources, Shanghai 201201, China.
  • Luo Z; ChemPartner, Shanghai 201203, China.
  • Fang C; ChemPartner, Shanghai 201203, China.
  • Tang H; ChemPartner, Shanghai 201203, China.
  • Lv X; ChemPartner, Shanghai 201203, China.
  • Nagaraja R; Agios Pharmaceuticals, Inc., Cambridge, Massachusetts 02139, United States.
  • Yang H; Agios Pharmaceuticals, Inc., Cambridge, Massachusetts 02139, United States.
  • Su SM; Agios Pharmaceuticals, Inc., Cambridge, Massachusetts 02139, United States.
  • Sui Z; Agios Pharmaceuticals, Inc., Cambridge, Massachusetts 02139, United States.
  • Dang L; Agios Pharmaceuticals, Inc., Cambridge, Massachusetts 02139, United States.
  • Yen K; Agios Pharmaceuticals, Inc., Cambridge, Massachusetts 02139, United States.
  • Popovici-Muller J; Agios Pharmaceuticals, Inc., Cambridge, Massachusetts 02139, United States.
  • Codega P; Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
  • Campos C; Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
  • Mellinghoff IK; Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
  • Biller SA; Agios Pharmaceuticals, Inc., Cambridge, Massachusetts 02139, United States.
ACS Med Chem Lett ; 11(2): 101-107, 2020 Feb 13.
Article en En | MEDLINE | ID: mdl-32071674
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ACS Med Chem Lett Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ACS Med Chem Lett Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos